RheumNow
Avatar

Colchicine in COVID-19 Patients: Can Colchicine Prevent Complications and Hospitalizations?

By RheumNow FEATURING John J. Cush
By RheumNow FEATURING John J. Cush
0 views
February 3, 2021
Comments 4
Login to view comments. Click here to Login

Recommended

AUTOPLAY
15:26
Cleveland Clinic Rheumatology and Immunology Series

The Facts About COVID-19 Delta Breakthrough Infection and Vaccine Bo…

Feat. L. Calabrese
16:14
Cleveland Clinic Rheumatology and Immunology Series

How the Pandemic Will Likely End for the Immunosuppressed and How to…

Feat. L. Calabrese
05:14
RheumNow

COVID-19 & CDC Mask Guidance: Do Fully Vaccinated People Need to…

Feat. J. Cush
09:09
Keck School of Medicine of USC

COVID-19 and RMDs (February Update): The Role of Hyperinflammatory M…

Feat. D. Arkfeld
14:51
ACR Convergence 2021 Coverage

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

Feat. S. Sattui Cortes
24:10
ACR Convergence 2021 Coverage

COVID-19 Hyper-Inflammation: Rheumatologic DMARD/Biologic Use

Feat. R. Q. Cron
26:52
RheumNow

GI Side Effects of IL-17 Inhibitors, Downstream Revenues from Rheuma…

Feat. J. Cush
32:27
University Hospitals

Epidemic Long COVID-19: Questions and Implications for Rheumatology

Feat. L. Calabrese
38:39
University Hospitals

Vaccines in Immunocompromised Patients

Feat. N. Singer
11:50
Yuzaiful Yusof

Breakthrough Infections and Predicting Moderate-to-Severe COVID Outc…

51:16
Yale School of Medicine

COVID-19 and Rheumatic Diseases

Feat. V. Chowdhary
11:48
RheumNow

Rheumatic Disease & COVID-19 Vaccination: Why 55+ y/o Population…

Feat. J. Cush
27:35
Cleveland Clinic Rheumatology

Vaccine Responses in Immune-Mediated Inflammatory Diseases: Challeng…

Feat. A. Kim
59:28
Cleveland Clinic Rheumatology

Through the Lens of COVID-19: How We Recognize and Defend Ourselves …

Feat. L. Calabrese
23:56
John J. Cush

October 2021 Update on FDA Approvals, News and the Latest Journal Ar…

23:51
RheumNow

Best of EULAR 2021: RheumNow Conference Highlights

Feat. J. Cush
06:01
RheumNow

Updates on Tofacitinib Safety & COVID-19: What Are the New Tofac…

Feat. J. Cush
14:37
The Journal of Rheumatology

The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know …

Feat. E. Silverman, J. B. Galloway
19:39
Cleveland Clinic Rheumatology

Principles of Managing COVID-19 in High Risk Outpatients

Feat. C. Calabrese
06:03
RheumNow

What Are the Advantages of IL-18 in JIA Disorders? What Is the Usabi…

Feat. J. Cush